Get started
ABBVIEABBVIEABBVIE

ABBVIE

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

4ABBV trade ideas

$ABBV Bearish Swing Trade PlanGreen Line - Entry Target Red Line - Exit Target Pink Line - Stop-Loss Highly suggest using Google to Search "Transparent Traders" if you're trying to get to the next level. Transparent Traders exists to solve the critical issues facing our traders, both large and small. Our unique approach is not only what differentiates us, but also what makes us successful. Our advanced Blackbox uses custom algorithms & predictive A.I. to locate the most accurate day or swing trades for the best chance of success.
NYSE:ABBVShort
by jonny_red32
ABBV, is it a buy right now?☝️ Losing patent protection for a top-selling blockbuster drug is a big setback for any pharmaceutical company, but this can also give us great opportunities. They have done a great strategic-movement by acquiring Allergan. It's down 18% from last July 17 high, earnings are close. I believe, yes, it's a good moment to START doing COST-AVERAGE. The price is almost getting closer to the 50% Fibonacci (from last Mar 20). I'm protecting an optimistic retracement to 127% (at $108.58) Fibonacci (drawing from today), very close to the analyst's current average price target at $109.21. A more conservative take profit would be at $95. - P/E GAAP (TTM) of 18.63, sector media of 35.57 👍 - Forward P/E of 6.94 👍 - PEG GAAP (TTM) of 0.29, sector media of 0.88 👍 - EV / EBITDA (TTM) of 13.76 in a sector media of 19.29 👍 - Debt / Eq of 5.4 😐 - Dividend yield of 5.60% 😍 Nothing else to say, it's a great company, with great dividends. I'm in! 👌 This isn't trading advice. I've no idea what I'm talking about 😉. Trade with caution! 🚨 Have a good day! 🤟
NYSE:ABBVLong
by UnknownUnicorn12013771
1
$ABBV AbbVie Inc. - Double Bottom, Bullish Options Activity$ABBV AbbVie Inc. - Looking like a possible double bottom just under $86 after about a two month bear move. Expecting a strong move in the near term once this can clear the 200d ema (currently ~$89.00). Note: earnings upcoming, expected 10/30/20. Huge Bullish Options Flow in this name today: $122M in January'21 calls traded today (varying strikes, most deep ITM), on avg 8x OI - 58k contracts in total. Definitely looks like a large hedge fund trade. Positive fundamental news out today (possible driver of bullish options activity): "The National Institutes of Health said is running a mid-stage clinical trial evaluating a monoclonal antibody it developed with the privately held Boehringer Ingelheim in combination with remdesivir as a COVID-19 treatment." Source: MarketWatch.com -> www.marketwatch.com Medium term target: $107 by year-end Note: This is NOT investment advice.
NYSE:ABBVLong
by Triple_Barrel_Capital
3